← FDA Drug Approvals (Drugs@FDA)

TAZAROTENE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: SOLARIS PHARMA CORP · Approved 2023-03-20

Drug application

FDA Application #

ANDA213644

Application type

Abbreviated New Drug Application (Generic)

Brand name

TAZAROTENE

Generic name

TAZAROTENE

Active ingredients

TAZAROTENE

Dosage form

GEL

Route

TOPICAL

Marketing status

Prescription

Sponsor

SOLARIS PHARMA CORP

Manufacturer

Solaris Pharma Corporation

First approval

2023-03-20

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown